Sign Up to like & get
recommendations!
0
Published in 2020 at "Brain, Behavior, and Immunity"
DOI: 10.1016/j.bbi.2020.04.039
Abstract: IMPORTANCE Schizophrenia and major depressive disorder (MDD) are associated with increased risks of immunologic disease and metabolic syndrome. It is unclear to what extent growth, immune or glucose dysregulations are similarly present in these disorders…
read more here.
Keywords:
drug first;
schizophrenia mdd;
growth;
first episode ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Neuroscience"
DOI: 10.3389/fnins.2023.1153439
Abstract: Objective The aim of the present study was to explore influencing factors of cognitive impairments and their interrelationships in drug-naïve, first-episode schizophrenia (SCZ). Methods Patients with drug naïve, first episode SCZ and healthy controls (HCs)…
read more here.
Keywords:
first episode;
oxidative stress;
volume;
drug first ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2022.853602
Abstract: Objective Microstate analysis is a powerful tool to probe the brain functions, and changes in microstates under electroencephalography (EEG) have been repeatedly reported in patients with schizophrenia. This study aimed to investigate the dynamics of…
read more here.
Keywords:
episode schizophrenia;
first episode;
drug first;
microstates drug ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2023.1151551
Abstract: Introduction Despite the previous inconsistent findings of structural and functional abnormalities of the thalamus in patients with major depressive disorder (MDD), the disruption of the thalamic nuclei in the pathophysiology of this disorder has not…
read more here.
Keywords:
thalamic nuclei;
first episode;
drug first;
drug ... See more keywords